NLA Resources
MASLD
6 Resources
Knowledge Center
The National Lipid Association is your destination for the science of lipid medicine. Now, everything we know is in one place.
MASLD
6 Available Resources
NAFLD/NASH
The Lipid Panel – Non-alcoholic Fatty Liver Disease
AHA Scientific Statement on Nonalcoholic Fatty Liver Disease
Nonalcoholic fatty liver disease (NAFLD) contributes to cardiovascular disease risk through dyslipidemia, insulin resistance, altered coagulation states, and increased inflammation.…
Dyslipidemia Management in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Nonalcoholic fatty liver disease (NAFLD) is the accumulation of hepatic fat in ≥ 5% of hepatocytes in the absence of…
Case Study: Pharmacotherapy for Dyslipidemia and Metabolic Dysfunction-Associated Steatotic Fatty Liver Disease
Clinical Case The patient is a 67-year-old white gentleman with type 2 diabetes mellitus (T2DM), hypertension (HTN), 20-pack-year smoking history,…
Nonalcoholic Fatty Liver Disease: The Hepatic Complication of Metabolic Dysmetabolism
Nonalcoholic fatty liver disease (NAFLD) is the main hepatic complication of obesity, diabetes and metabolic syndrome. Its prevalence has risen…
Join the NLA
Become A Member
When you become a member of the NLA, you become part of a collegial multidisciplinary group of leaders dedicated to improving lipid and cardiometabolic health.
